TenderDekho Logo
Closed GEM

Government Tender Published for vaccine human papillomavirus 6, 11, 16, 18 recombinant in ALWAR, RAJASTHAN

Bid Publish Date

13-Jan-2025, 4:26 pm

Bid End Date

04-Feb-2025, 9:00 am

Progress

Issue13-Jan-2025, 4:26 pm
Technical02-Apr-2025, 8:56 am
AwardCompleted
Explore all 5 tabs to view complete tender details

Quantity

400

Bid Type

Two Packet Bid

Categories 1

Public procurement opportunity for Indian Army vaccine human papillomavirus 6, 11, 16, 18 recombinant in ALWAR, RAJASTHAN. Quantity: 400 issued by. Submission Deadline: 04-02-2025 09: 00: 00. View full details and respond.

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

Yes

Item Category

vaccine human papillomavirus 6, 11, 16, 18 recombinant

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENTINDIAN ARMY

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 4

GeM-Bidding-7314190.pdf

Main Document

DOC

OTHER

Buyer uploaded ATC document

ATC

DOC

OTHER

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Authorization Certificate

6

OEM Annual Turnover

7

Additional Doc 1 (Requested in ATC)

8

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

9

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Technical Results

S.No Seller Item Date Status
1
BHARGAVA MEDICAL STORES   Under PMA
Make : CERVAVAC Model : vaccine human papillomavirus 6, 11, 16, 18 recombi Title : vaccine human papillomavirus 6, 11, 16, 18 recombinant04-02-2025 08:56:21
2
JAIPUR AGENCIES   Under PMA
Make : GARDASIL Model : Medicine Title : vaccine human papillomavirus 6, 11, 16, 18 recombinant03-02-2025 18:32:46
3
TOASHA VACCINES HOUSE   Under PMA
Make : SERUM INSTITUTE Model : CERVAVAC Title : Human papilloma virus quadrivalent (Types 6, 11, 16, 18) vaccine, Recombinant PFS of 0.5 ml03-02-2025 12:05:02

Reverse Auction Results Final Prices

These are the final prices after the reverse auction event. Prices may be lower than initial bids.

Rank Seller Final Price Item
L1TOASHA VACCINES HOUSE(MII)   Under PMA Winner ₹5,64,000Item Categories : vaccine human papillomavirus 6, 11, 16, 18 recombinant
L2BHARGAVA MEDICAL STORES (MII)   Under PMA₹5,65,976Item Categories : vaccine human papillomavirus 6, 11, 16, 18 recombinant

🎉 L1 Winner

TOASHA VACCINES HOUSE(MII)   Under PMA

Final Price: ₹5,64,000

Frequently Asked Questions

Key insights about RAJASTHAN tender market

What are the eligibility requirements for participating in this tender?

The eligibility requirements include being a registered entity capable of supplying the specified HPV vaccine. Bidders must have a minimum average annual turnover of 2 Lakhs, alongside an OEM average turnover of 5 Lakhs. MSEs and startups are granted exemptions for years of experience, thereby broadening participation.

What technical certifications are required for this tender?

Bidders are required to submit various technical documents including experience criteria, OEM authorization, and compliance with the BoQ specifications. Specific details can be found in the Additional Terms & Conditions (ATC) provided in the documentation.

What is the registration process for this tender?

The registration process involves ensuring that the bidder is a recognized entity on the GeM platform. Necessary documents and credentials must be submitted through the platform for verification and approval.

What document formats are accepted for submission?

The accepted document formats generally include PDFs for reports, certificates, and technical documentation, ensuring compatibility with the GeM submission platform. Specific document types will be outlined in the tender conditions.

What are the testing criteria outlined for the vaccine?

The testing criteria will include adherence to international quality standards for vaccine production and efficacy. Compliance with the specified BoQ specifications is mandatory for approval.

What are the payment terms for this tender?

Payment terms typically include milestones based on delivery and quality approval of the vaccine. Additional details on payment terms are provided in the tender documents, outlining any specifics related to timing and method.

How is the Earnest Money Deposit (EMD) structured for this tender?

Details regarding the Earnest Money Deposit (EMD) requirements will be included within the tender document. Bidders should refer to these requirements closely to fulfill submission criteria effectively.

How are performance security requirements assessed?

Performance security is usually required to safeguard contractual obligations. The specifics on amounts and conditions will be explicitly listed in the tender documentation provided to eligible bidders.

What is the submission method for bids?

Bids must be submitted electronically via the designated GeM portal. Bidders are required to follow the submission guidelines outlined in the tender documentation to ensure compliance.

What are the key timelines and deadlines for this tender?

While exact dates may vary, essential timelines and deadlines for bid submissions can be found within the tender document. Bidders should adhere closely to these dates for successful participation.

How does the evaluation and selection process work?

The evaluation and selection process will include both technical evaluation and price assessment. The method will favor the 50% lowest priced technically qualified bidders, as outlined in the tender evaluation criteria.

How will the results of the tender be communicated?

Results will typically be communicated through official notifications issued via the GeM portal, ensuring that all bidders receive pertinent information related to their submissions.

Are there any benefits for MSEs participating in this tender?

MSEs participating in this tender benefit from relaxed eligibility criteria concerning years of experience and other regulatory requirements, thus promoting inclusivity and diversity in bidding.

What provisions exist for startups in this tender?

Startups are afforded exemptions similar to MSEs regarding operational experience, fostering an inviting environment for new businesses to engage in government contracting.

How does this tender comply with 'Make in India' policies?

This tender actively promotes local production and procurement through MSE and startup provisions, aligning with the Make in India initiatives, fostering local economic growth.

What are the rules regarding local content procurement?

While specific requirements may vary, details on local content rules are generally outlined in the tender documents, emphasizing support for domestic manufacturers and suppliers within the procurement process.